Thoughts and context1 May 2026 11:11
Guys, I sense there is the potential of some confusion here, so I will try and share my opinion in a constructive way, albeit I speak from a position of supporting the company for circa 9 years or more, I have supported numerous fund raises and I am a loan note holder, which I would add was done so on a non secured basis,
There were 1.4bn shares at suspension and 390M is issued to CLN, so approx 25% dilution, to ensure we reached this stage,
80% of litigation award is confirmed as ringfenced and I would concede, I was expecting this to be around 60-40, so this more than offsets CLN.
Please be mindful, that since we were suspended in March 2024, it took another 18months to secure lit funding, which the CLN's made possible (if no lit funding and no readmission the CLN providers could have lost all funds as LampeConway have £1.2M debt) and that process as I have detailed before was forensic in terms of due diligence, this I would add is a very point of future value, in terms of the potential award?
Plus, LC could have converted their loan much below 0.1p (or put LOGP in bankruptcy) and existing shareholders would have had nothing.
In my opinion we now have upside in the plc if the 'new Lansdowne' creates value and we are protected from future dilution on 80% of any award under the claim.
I think board have done a remarkable job and their close supporters have also, this company could easily have gone bust, or diluted existing to oblivion, or given notional percentage to existing shareholders rather than 80%.
It will be of course, the new funders company, but the old funders and shareholders have definitely been looked after, this was never going to be ideal and please everyone(but blame Ireland for that, not the board or CLN holders) and I certainly believe shareholders are a lot better off now than they were 2yrs ago and we have a number of very positive and material events within our near reach,..excuse the ramble, but hopefully this adds some helpful insight,…GL S